Key facts
- It has raised $730K; the latest was Early Stage VC ($730K) in Mar 2026.
- Notable investors include Shenzhen Huicai Equity Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Guanhua Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Guanhua Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guanhua Biotechnology
Manufacturer of advanced material inputs designed for energy storage and industrial applications. The company offers fuel processing, lithium oxide powder production, and recycling of industrial waste streams such as glass and metals, enabling markets in renewable energy, high-end ceramics, and specialty glass to access stable raw material supply, improved purity standards, enhanced conductivity properties, and scalable solutions for circular economy adoption, while supporting broader industrial efficiency and environmental compliance requirements.
- Sector
- Materials and Resources
- HQ
- Xinyu, China
- Founded
- 2022
- Employees
- 38
- Ownership
- Privately Held (backing)
Guanhua Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guanhua Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guanhua Biotechnology in its N-PORT filings yet. We sweep new filings monthly.